Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

NCT03962881 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B Vaccine

Interventions

BIOLOGICAL: 20 µg recombinant hepatitis B vaccine at months 0, 1, and 6
BIOLOGICAL: 20 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6
BIOLOGICAL: 60 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6

Sponsor

Shanxi Medical University

Collaborators

[object Object]